Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.

Gynecologic oncology - 1 Jan 2006

Olivier R I, Lubsen-Brandsma M A C, Verhoef S, van Beurden M

Abstract excerpt

OBJECTIVES: The main objective of screening is to identify cases of ovarian cancer in early stages. However, screening of women in the general population is ineffective due to a failure of detecting early-stage disease and high false positive rates of CA125 and transvaginal ultrasound (TVU) monitoring. The purpose of this study is to evaluate ovarian cancer screening by means of pelvic examination, serum CA125...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Monitoring, Physiologic

Share to Ovarian Neoplasms

Share to Physical Examination

Share to Ultrasonography

Source

Identifiers

PMID: 16188302
DOI: 10.1016/j.ygyno.2005.08.038

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.PMID 16188302Read ↗

Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.Semantic proximity Read ↗

Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study.Semantic proximity Read ↗

Surveillance of women at high risk for hereditary ovarian cancer is inefficient.Semantic proximity Read ↗

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.Semantic proximity Read ↗

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.Semantic proximity Read ↗

CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients.Semantic proximity Read ↗

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.Semantic proximity Read ↗

Early diagnosis of peritoneal carcinoma based on a subtle rise in serum CA125 level within the normal range in a BRCA2 mutation carrier with serous tubal intraepithelial carcinoma discovered after risk-reducing salpingo-oophorectomy: A case report and literature review.Semantic proximity Read ↗

Use of CA-125 and ultrasound in high-risk women.Semantic proximity Read ↗

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.Semantic proximity Read ↗

Prophylactic oophorectomy: clinical considerations.Semantic proximity Read ↗

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.